Efficiency observation of blood purification therapy combined with Shenfu Injection in treatment of patients with septic shock

XU Rong

doi:10.7619/jcmp.201915003

Journal of Clinical Medicine in Practice > 2019 > 23(15): 9-13. > DOI: 10.7619/jcmp.201915003

XU Rong. Efficiency observation of blood purification therapy combined with Shenfu Injection in treatment of patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2019, 23(15): 9-13. DOI: 10.7619/jcmp.201915003

Citation:

PDF (652 KB)

Efficiency observation of blood purification therapy combined with Shenfu Injection in treatment of patients with septic shock

XU Rong

Intensive Care Unit, East Branch of Suzhou Municipal Hospital, Suzhou, Jiangsu, 215001

More Information

Received Date: April 14, 2019
Revised Date: June 27, 2019
Available Online: February 23, 2021
Published Date: August 14, 2019

Graphical Abstract

Abstract

Abstract

Objective To investigate the effect of blood purification combined with Shenfu Injection in the treatment of septic shock.
Methods Totally 68 patients with septic shock were randomly divided into combined group and routine group, with 34 cases in each group. The routine group was treated by blood perfusion (HP) combined with continuous veno-venous hemofiltration (CVVH), and the combined group was treated with Shenfu Injection on the basis of routine group. The levels of inflammatory cytokines [tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), C reactive protein (CRP), procalcitonin (PCT)] and vital signs [Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ), mean arterial pressure (MAP), blood lactic acid (Lac), oxygenation index (OI)] at different time points were compared between two groups, and levels of serum inflammatory cytokines were compared between survival and death patients.
Results After the first, second and third treatments, the levels of inflammatory cytokines in both groups were significantly lower than those before treatment, and the levels of inflammatory cytokines in the combined group were significantly lower than those in the routine group (P < 0.05). After the first, second and third treatments, the APACHE Ⅱ scores and Lac levels in both groups were significantly lower than those before treatment, the levels of MAP and OI were significantly higher than those before treatment, and APACHE Ⅱ scores, Lac levels and the levels of MAP and OI in the combined group were significantly better than those in the routine group (P < 0.05). The 28-day survival rate was 67.65% in the combined group and 58.82% in the routine group, which showed no significant difference (P>0.05). The levels of TNF-α, IL-10, CRP and PCT of survival patients in the combined group were significantly lower than those of survival patients in the routine group (P < 0.05). There were no significant differences in the above indexes in the died patients between the two groups (P > 0.05).
Conclusion Shenfu Injection combined with HP and CVVH can effectively reduce the levels of inflammatory cytokines in patients with septic shock, increase circulation blood volume of tissue, reduce the level of Lac, improve the prognosis of patients, and improve the survival rate of patients.

FullText(HTML)

References (23)

References

[1]	Lamontagne F, Day A G, Meade M O, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock[J]. Intensive Care Med, 2018, 44(1): 12-21. doi: 10.1007/s00134-017-5016-5
[2]	Singer M, Deutschman C S, Seymour C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
[3]	Prescott H C, Angus D C. Postsepsis morbidity[J]. JAMA, 2018, 319(1): 91-102. doi: 10.1001/jama.2017.19809
[4]	Reinhart K, Daniels R, Kissoon N, et al. Recognizing sepsis as a global health priority: a WHO resolution[J]. N Engl J Med, 2017, 377(5): 414-417. doi: 10.1056/NEJMp1707170
[5]	戴喜明, 高青豹, 胡清甫. 醒脑静注射液联合床旁高流量持续血液净化治疗脓毒性休克48例临床分析[J]. 重庆医学, 2016, 45(14): 1978-1980. doi: 10.3969/j.issn.1671-8348.2016.14.037
[6]	Seymour C W, Rosengart M R. Septic shock: advances in diagnosis and treatment[J]. JAMA, 2015, 314(7): 708-717. doi: 10.1001/jama.2015.7885
[7]	中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会, 于学忠, 等. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 临床急诊杂志, 2018, 19(9): 567-588. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201809001.htm
[8]	董小荣, 马莉, 甄玲玲, 等. 血液灌流联合血液滤过治疗脓毒性休克的疗效观察[J]. 中国急救复苏与灾害医学杂志, 2016, 10(7): 691-693. doi: 10.3969/j.issn.1673-6966.2016.07.013
[9]	Cecconi M, Hofer C, Teboul J L, et al. Fluid challenges in intensive care: the FENICE study[J]. Intensive Care Med, 2015, 41(9): 1529-1537. doi: 10.1007/s00134-015-3850-x
[10]	Guo Y, Gao W, Yang H X, et al. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis[J]. Heart & Lung, 2016, 45(5): 454-459. http://www.sciencedirect.com/science/article/pii/S014795631630098X
[11]	郭晓华, 王郑莲, 刘亚楠, 等. 血液滤过联合乌司他丁治疗脓毒性休克的分子机制[J]. 南方医科大学学报, 2015, 35(8): 1189-1192, 1196. doi: 10.3969/j.issn.1673-4254.2015.08.021
[12]	Seymour C W, Liu V X, Iwashyna T J, et al. Assessment of clinical criteria for sepsis[J]. JAMA, 2016, 315(8): 762-774. doi: 10.1001/jama.2016.0288
[13]	Li Y, Zhang X C, Lin P H, et al. Effects of shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial[J]. Evidence-Based Complementary and Alternative Medicine, 2016, 2016: 2565169. http://www.ncbi.nlm.nih.gov/pubmed/27818701
[14]	Mou Z J, Lv Z, Li Y, et al. Clinical effect of shenfu injection in patients with septic shock: a meta-analysis and systematic review[J]. Evid Based Complement Alternat Med, 2015, 2015: 863149.
[15]	何荣, 孔立. 参附注射液治疗感染性休克的临床研究[J]. 陕西中医, 2016, 37(4): 424-425. doi: 10.3969/j.issn.1000-7369.2016.04.020
[16]	乔宋璇, 卓道勤, 张丹阳, 等. 参附注射液对感染性休克早期微循环的影响[J]. 中国中医急症, 2016, 25(1): 135-136. doi: 10.3969/j.issn.1004-745X.2016.01.045
[17]	郝浩, 孔立, 韩宁, 等. 参附注射液对脓毒性休克血流动力学及多糖包被的影响[J]. 中成药, 2017, 39(11): 2437-2440. doi: 10.3969/j.issn.1001-1528.2017.11.052
[18]	王文龙. 参附注射液治疗脓毒性休克作用机理分析[J]. 新中医, 2015, 47(3): 3-5. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201503003.htm
[19]	陈佳顺, 姚盛. 参附注射液治疗难治性脓毒血症并休克的临床观察[J]. 中国实用医药, 2016, 11(19): 161-162. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA201619116.htm
[20]	刘波, 单南冰. ICU危重患者APACHEⅡ评分变化率和临床预后的关系[J]. 内科急危重症杂志, 2017, 23(2): 142-144. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW201702017.htm
[21]	周洪, 江跃全, 綦俊, 等. 心肌型脂肪酸结合蛋白联合APACHEⅡ评分对急性肺栓塞病情及预后的评估价值[J]. 第三军医大学学报, 2016, 38(9): 1026-1030. https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX201609030.htm
[22]	刘思齐, 王琦, 向华. 乳酸联合APACHEⅡ评分系统对老年社区获得性肺炎患者预后的评估价值[J]. 空军医学杂志, 2018, 34(2): 138-141. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZY201802019.htm
[23]	包磊, 张敏, 颜培夏, 等. 动脉血乳酸及其清除率预测感染性休克患者预后的回顾性研究[J]. 中华危重病急救医学, 2015, 27(1): 38-42.

Cited By

Cited by

Periodical cited type(18)

1.	马肖寒，周凤丽，周莉. 呼吸机管路低位摆放预防行机械通气患者呼吸机相关性肺炎的效果观察. 山东医学高等专科学校学报. 2025(01): 96-98 .
2.	李晓，胡加运，秦梦. 革兰阴性杆菌感染呼吸机相关性肺炎患者病原菌分布及耐药性. 中国民康医学. 2024(05): 16-18 .
3.	黄小芬，夏良娥，赵世元，黄敏敏. 建立梯度提升机模型预测RICU机械通气并发呼吸机相关性肺炎患者的短期预后. 广西医学. 2024(01): 78-83 .
4.	郑丽欢. 某院ICU呼吸机相关性肺炎患者呼吸道标本中病原菌的检出情况和耐药性分析. 抗感染药学. 2024(02): 177-180 .
5.	徐海蓉，陆恺，陈林祥. 有创-无创序贯机械通气治疗重症肺炎合并呼吸衰竭的效果观察. 大医生. 2024(07): 96-98 .
6.	钟晓莉，余林，邓海波，张帆，罗洲. 236例ICU呼吸机相关性肺炎患者病原菌分布及耐药性分析. 中国病原生物学杂志. 2024(07): 838-841 .
7.	邹君俊. 一种免倾倒呼吸机集水杯的设计与使用. 科技与创新. 2024(13): 57-58+64 .
8.	张先梅，文艳，哈海霞，罗永丽，张艳. 重症肺炎患儿呼吸机相关性肺炎发生风险列线图模型构建. 临床医学研究与实践. 2024(27): 9-13 .
9.	陈妙莉，黄腊梅，赵红苑. 基于循证理念主导的早期康复活动在ICU机械通气患者中的应用效果. 现代养生. 2024(20): 1584-1588 .
10.	伏帅. 慢阻肺合并呼吸衰竭机械通气患者发生呼吸机相关性肺炎的危险因素分析. 黑龙江医药科学. 2024(06): 149-151 .
11.	吴小杰，郜永月. 呼吸机相关性肺炎的影响因素及护理预防策略. 现代养生. 2024(22): 1750-1753 .
12.	张楠，李红双，兰迎春. 基于网式控制模式的吸痰方案优化对重症机械通气患者VAP的预防效果研究. 齐鲁护理杂志. 2024(21): 129-131 .
13.	王一山，阮萍，章夏萍. 基于渥太华研究应用模式的肺部感染预防方案在ICU机械通气病人中的应用. 循证护理. 2024(24): 4543-4547 .
14.	丁剑，周俊. 慢性阻塞性肺疾病合并肺炎患者的痰培养菌种分布及耐药性分析. 实用临床医药杂志. 2023(01): 60-63+67 . 本站查看
15.	王彦芬，朱萍莲，刘玉芳，凌碧珍，王航莉，郑丽华. 重症监护室患者呼吸机相关性肺炎的影响因素分析及预防性应对措施探讨. 中西医结合护理(中英文). 2023(02): 145-147 .
16.	周红，李志红，徐丽红. 分级肺康复护理对ICU机械通气病人的应用效果. 全科护理. 2023(34): 4842-4845 .
17.	王进，李玉侠. ICU老年机械通气患者呼吸机相关性肺炎风险预测模型的构建探讨. 中国实用医药. 2023(23): 52-56 .
18.	荆惠，关胜男，谢凯，王海峰. 纤维支气管镜肺泡灌洗辅助治疗重症呼吸机相关性肺炎的Meta分析. 实用临床医药杂志. 2022(21): 1-7+13 . 本站查看

Other cited types(3)

Get Citation

PDF

XML

Article views (159) PDF downloads (5) Cited by(21)

Turn off MathJax

Article Contents

Abstract

References

Efficiency observation of blood purification therapy combined with Shenfu Injection in treatment of patients with septic shock

Abstract

References

Cited by

Periodical cited type(18)

Other cited types(3)

Catalog

Export File

Citation

Format

Content